DK155329C - 7-AMINOCEPHALOSPORINES USED AS INTERMEDIATES IN THE PREPARATION OF THERAPEUTIC EFFECTIVE 7-ACYLAMINO-CEPHALOSPORINES - Google Patents

7-AMINOCEPHALOSPORINES USED AS INTERMEDIATES IN THE PREPARATION OF THERAPEUTIC EFFECTIVE 7-ACYLAMINO-CEPHALOSPORINES

Info

Publication number
DK155329C
DK155329C DK453687A DK453687A DK155329C DK 155329 C DK155329 C DK 155329C DK 453687 A DK453687 A DK 453687A DK 453687 A DK453687 A DK 453687A DK 155329 C DK155329 C DK 155329C
Authority
DK
Denmark
Prior art keywords
aminocephalosporines
cephalosporines
acylamino
intermediates
preparation
Prior art date
Application number
DK453687A
Other languages
Danish (da)
Other versions
DK155329B (en
DK453687A (en
DK453687D0 (en
Inventor
Marc Montavon
Roland Reiner
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of DK453687A publication Critical patent/DK453687A/en
Publication of DK453687D0 publication Critical patent/DK453687D0/en
Publication of DK155329B publication Critical patent/DK155329B/en
Application granted granted Critical
Publication of DK155329C publication Critical patent/DK155329C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/553Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56One oxygen atom and one sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D253/00Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/061,2,4-Triazines
    • C07D253/0651,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/071,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D253/075Two hetero atoms, in positions 3 and 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36Methylene radicals, substituted by sulfur atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK453687A 1974-06-21 1987-08-28 7-AMINOCEPHALOSPORINES USED AS INTERMEDIATES IN THE PREPARATION OF THERAPEUTIC EFFECTIVE 7-ACYLAMINO-CEPHALOSPORINES DK155329C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH853774A CH609989A5 (en) 1974-06-21 1974-06-21 Process for the preparation of acyl derivatives
CH853774 1974-06-21

Publications (4)

Publication Number Publication Date
DK453687A DK453687A (en) 1987-08-28
DK453687D0 DK453687D0 (en) 1987-08-28
DK155329B DK155329B (en) 1989-03-28
DK155329C true DK155329C (en) 1989-08-07

Family

ID=4341690

Family Applications (2)

Application Number Title Priority Date Filing Date
DK271975A DK153155C (en) 1974-06-21 1975-06-17 ANALOGY PROCEDURE FOR THE PREPARATION OF CEPHALOSPORINES
DK453687A DK155329C (en) 1974-06-21 1987-08-28 7-AMINOCEPHALOSPORINES USED AS INTERMEDIATES IN THE PREPARATION OF THERAPEUTIC EFFECTIVE 7-ACYLAMINO-CEPHALOSPORINES

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK271975A DK153155C (en) 1974-06-21 1975-06-17 ANALOGY PROCEDURE FOR THE PREPARATION OF CEPHALOSPORINES

Country Status (25)

Country Link
JP (1) JPS625917B2 (en)
AT (1) AT337897B (en)
AU (1) AU498387B2 (en)
BE (1) BE830455A (en)
BR (1) BR7503782A (en)
CA (1) CA1111021A (en)
CH (1) CH609989A5 (en)
CU (1) CU34293A (en)
DD (1) DD121113A5 (en)
DE (1) DE2527291A1 (en)
DK (2) DK153155C (en)
FI (1) FI751815A (en)
FR (1) FR2275215A1 (en)
GB (1) GB1471804A (en)
HU (1) HU170576B (en)
IE (1) IE41888B1 (en)
IL (1) IL47299A (en)
LU (1) LU72771A1 (en)
NL (1) NL180665C (en)
NO (1) NO752202L (en)
NZ (1) NZ177508A (en)
PH (1) PH13030A (en)
SE (1) SE431755B (en)
SU (2) SU635873A3 (en)
ZA (1) ZA753086B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7805715A (en) * 1977-06-03 1978-12-05 Hoffmann La Roche METHOD FOR PREPARING ACYL DERIVATIVES.
JPS5419990A (en) * 1977-07-14 1979-02-15 Shionogi & Co Ltd Dihydrotriazinylthioxacephalosporin
MC1259A1 (en) * 1978-05-30 1980-01-14 Hoffmann La Roche ACYL DERIVATIVES
FR2474030A1 (en) * 1980-01-17 1981-07-24 Rhone Poulenc Ind 2-Mercapto-1,2,4-triazine, 1,3,4-triazole or tetrazole derivs. - useful as intermediates for antibacterial cephalosporin(s)
FR2494278A1 (en) * 1980-11-20 1982-05-21 Rhone Poulenc Ind NEW DERIVATIVES OF CEPHALOSPORIN, THEIR PREPARATIONS AND THE MEDICINAL PRODUCTS CONTAINING THEM
JP2004538265A (en) * 2001-04-19 2004-12-24 ビオフェルマ ムルシア,エス.アー. Method for producing 3-cephalosporanic acid derivative using α-keto acid derivative
EP2250156B1 (en) 2008-03-05 2015-05-06 Merck Patent GmbH Pyrazinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3868369A (en) * 1972-11-14 1975-02-25 Smithkline Corp 3-heterocyclicthiomethylcephalosporins

Also Published As

Publication number Publication date
SE431755B (en) 1984-02-27
PH13030A (en) 1979-11-15
SE7506908L (en) 1975-12-22
DK153155B (en) 1988-06-20
ZA753086B (en) 1976-04-28
AU8191275A (en) 1976-12-09
JPS5113793A (en) 1976-02-03
IL47299A (en) 1979-01-31
JPS625917B2 (en) 1987-02-07
DE2527291C2 (en) 1988-01-14
LU72771A1 (en) 1977-03-04
NL180665B (en) 1986-11-03
NZ177508A (en) 1978-04-03
DK155329B (en) 1989-03-28
IE41888L (en) 1975-12-21
IL47299A0 (en) 1976-10-31
CA1111021A (en) 1981-10-20
FR2275215B1 (en) 1980-05-16
GB1471804A (en) 1977-04-27
AU498387B2 (en) 1979-03-08
FR2275215A1 (en) 1976-01-16
BR7503782A (en) 1976-07-06
SU635873A3 (en) 1978-11-30
CU34293A (en) 1979-01-16
NL180665C (en) 1987-04-01
DK453687A (en) 1987-08-28
NO752202L (en) 1975-12-23
NL7507390A (en) 1975-12-23
FI751815A (en) 1975-12-22
SU589921A3 (en) 1978-01-25
ATA476975A (en) 1976-11-15
AT337897B (en) 1977-07-25
IE41888B1 (en) 1980-04-23
CH609989A5 (en) 1979-03-30
DE2527291A1 (en) 1976-01-08
DK453687D0 (en) 1987-08-28
DD121113A5 (en) 1976-07-12
DK271975A (en) 1975-12-22
DK153155C (en) 1988-10-31
HU170576B (en) 1977-07-28
BE830455A (en) 1975-12-22

Similar Documents

Publication Publication Date Title
DK142237C (en) CONTINUOUS PROCEDURE FOR THE PREPARATION OF ALCOXYSILAN
DK144298C (en) PROCEDURE FOR THE PREPARATION OF ALKYL-TERT BUTYLETHERS
DK385475A (en) PROCEDURE FOR THE PREPARATION OF SECOPROSTAGLANDINS
DK141849C (en) PROCEDURE FOR THE PREPARATION OF SEA-VINYLAROMATE PODECOPOLYMERS
DK155329C (en) 7-AMINOCEPHALOSPORINES USED AS INTERMEDIATES IN THE PREPARATION OF THERAPEUTIC EFFECTIVE 7-ACYLAMINO-CEPHALOSPORINES
DK206375A (en) PROCEDURE FOR THE PREPARATION OF THIAPROSTAGLANDINS
DK574075A (en) PROCEDURE FOR THE PREPARATION OF 2-METHOXYBENZAMIDES
DK583775A (en) PROCEDURE FOR THE PREPARATION OF 3-FLUOROBENZODIAZEPINES
DK543875A (en) PROCEDURE FOR THE PREPARATION OF HYDROXYPHENYLACETONITRILES
DK528475A (en) PROCEDURE FOR THE PREPARATION OF TETRAMETHYLETHYLENDIAMINE
NO143023C (en) DIFENYLAMINES FOR USE AS INTERMEDIATES IN THE PREPARATION OF RODENTICID EFFECTIVE COMPOUNDS
DK187878A (en) N-PHENYL-2-AZACYCLOINDOL COMPOUNDS FOR USE AS INTERMEDIATE PRODUCTS IN THE PREPARATION OF 2-SUBSTITUTED N-PHENYL-2-AZACYCLOINDOL COMPOUNDS
DK137539C (en) PROCEDURE FOR THE PREPARATION OF 11BETA-FLUORO-4-ANDROSTEN-3-ONERS
DK555680A (en) BENZOCYCLOPTATHIOPHENDER DERIVATIVES USED AS INTERMEDIATES IN THE PREPARATION OF THERAPEUTICALLY EFFECTIVE BENZOCYCLOPTATHIOPHENDER DERIVATIVES
DK155671C (en) 7-ALFA-ALCOXY-7-BETA-BENZYLIDEENAMINO-3-CEPHEM-4-CARBOXYLATES USED AS INTERMEDIATES IN THE PREPARATION OF 7-ALFA-ALCOXYCEPHALOSPORINES AND PROCEDURES
DK593575A (en) PROCEDURE FOR THE PREPARATION OF TRICHLORETHYLCHLOROF
DK137721C (en) PROCEDURE FOR THE PREPARATION OF ALFA-OXOTHIODIMETHYLAMIDES
DK396175A (en) PROCEDURE FOR THE PREPARATION OF BENZYLAMINOAL CANCIDS
DK543975A (en) PROCEDURE FOR THE PREPARATION OF 4-HYDROXY-3-METHOXYPHENYLACETONITRIL
DK155660C (en) 1-ARYLOXY-4-CHLOR-2-BUTANOLS USED AS INTERMEDIATES IN THE PREPARATION OF 1-ARYLOXY-4-AMINO-2-BUTANOLS
DK233375A (en) PROCEDURE FOR THE PREPARATION OF SUBSTITUTED PHENYLMERCAPTO-BENZIMIDAZOLES
DK137640C (en) PROCEDURE FOR THE PREPARATION OF ACETOACETAMIDE-N-SULFOFLUORIDE
DK499975A (en) PROCEDURE FOR THE PREPARATION OF PYRAZOLIDINONS
DK221875A (en) PROCEDURE FOR THE PREPARATION OF CEPHALOSPORINESTERES
DK576575A (en) PROCEDURE FOR THE PREPARATION OF ALFA-6-DESOXYTETRACYCLINES

Legal Events

Date Code Title Description
PUP Patent expired